SCHEMBL258259

SCHEMBL258259

CCCCOCCc1ccncc1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 4/20 0.47
KDM6B O15054 3/20 0.47
GABRP O00591 2/20 0.42
GABRD O14764 2/20 0.42
GABRA1 P14867 2/20 0.42
GABRB1 P18505 2/20 0.42
GABRG2 P18507 2/20 0.42
GABRB3 P28472 2/20 0.42
GABRA5 P31644 2/20 0.42
GABRA3 P34903 2/20 0.42
GABRA2 P47869 2/20 0.42
GABRB2 P47870 2/20 0.42
GABRA4 P48169 2/20 0.42
GABRE P78334 2/20 0.42
GABRA6 Q16445 2/20 0.42
GABRG1 Q8N1C3 2/20 0.42
GABRG3 Q99928 2/20 0.42
GABRQ Q9UN88 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
RARB P10826 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4005290 0.85 GABRP (0.55) KDM4CKDM6BGABRPGABRDGABRA1
SCHEMBL5002411 0.82 KDM6B (0.51) KDM4CKDM6BGABRPGABRDGABRA1
SCHEMBL4998341 0.82 KDM6B (0.51) KDM4CKDM6BGABRPGABRDGABRA1
SCHEMBL4998464 0.82 KDM6B (0.51) KDM4CKDM6BGABRPGABRDGABRA1
SCHEMBL5002870 0.82 KDM6B (0.51) KDM4CKDM6BGABRPGABRDGABRA1
SCHEMBL6072747 0.82 KDM6B (0.51) KDM4CKDM6BGABRPGABRDGABRA1
SCHEMBL258369 0.82 KDM4C (0.51) KDM4CKDM6BGABRPGABRDGABRA1
Hydrochloric Acid SCHEMBL5739434 0.81 KDM4C (0.50) KDM4CKDM6BGABRPGABRDGABRA1
SCHEMBL17530462 0.80 FOLH1 (0.51) L3MBTL1RARBRARAKDM4EALDH1A1
SCHEMBL123203 0.77 KDM4C (0.51) KDM4CKDM6BGABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517880-B1 PRODUCTION OF CIS-PELLITORIN AND USE AS A FLAVOURING SYMRISE AG (DE) 2011-01-05 EP claimed
WO-2008049651-A1 PERFORMANCE-ENHANCED COSMETIC COMPOSITIONS WITH PURINE AND/OR PURINE DERIVATIVES HENKEL AG & CO. KGAA (DE) 2008-05-02 WO claimed
EP-1880705-A2 Brightening and/or colouring composition with improved product sensation HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2008-01-23 EP claimed
EP-1842573-A2 Brightening and/or colouring agent with improved product sensation Henkel Kommanditgesellschaft auf Aktien (DE) 2007-10-10 EP claimed
EP-4699452-A2 OBTAINING A VOLATILE FRACTION FROM JUICES OR ALCOHOLIC BEVERAGES Symrise AG (DE) 2026-02-25 EP disclosed
US-20260041109-A1 ROBUST FLAVOR EMULSIONS INT FLAVORS & FRAGRANCES INC (US) 2026-02-12 US disclosed
EP-3836799-B1 OBTAINING A VOLATILE FRACTION FROM JUICES OR ALCOHOLIC BEVERAGES SYMRISE AG (DE) 2025-11-26 EP disclosed
US-12419815-B2 Microcapsule compositions stabilized with viscosity control agents INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2025-09-23 US disclosed
EP-4615958-A1 CELL COMPOSITIONS Givaudan SA (CH) 2025-09-17 EP disclosed
US-12357547-B2 Compositions containing microcapsules INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2025-07-15 US disclosed
US-12324452-B2 Delivery systems and methods of preparing the same INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2025-06-10 US disclosed
CN-119821018-A System and method for printing and drying fragrances and perfumes 国际香料和香精公司 2025-04-15 CN disclosed
WO-2004000787-A2 PRODUCTION OF CIS-PELLITORIN AND USE AS A FLAVOURING SYMRISE GMBH & CO. KG (DE) 2003-12-31 WO disclosed
WO-2003106404-A1 USE OF ALKYLAMIDOMANDELATES AS FLAVOURINGS SYMRISE GMBH & CO. KG (DE) 2003-12-24 WO disclosed
WO-2003068128-A2 MASSAGE APPLIANCE COMPRISING A STORAGE CONTAINER AND A SETTING MECHANISM FOR SETTING A CHARACTERISTIC MASSAGE VALUE BEIERSDORF AG (DE) 2003-08-21 WO disclosed
EP-1326955-A1 MULTI-PHASE SOAP HAARMANN & REIMER GMBH (DE) 2003-07-16 EP disclosed
EP-1323356-A2 Use of ferulic amides as flavouring agents HAARMANN & REIMER GMBH (DE) 2003-07-02 EP disclosed
WO-2002024857-A1 MULTI-PHASE SOAP HAARMANN & REIMER GMBH (DE) 2002-03-28 WO disclosed
EP-1079832-A1 USE OF VITAMIN PP COMPOUNDS Klinge Pharma GmbH (DE) 2001-03-07 EP disclosed
WO-1999053920-A1 USE OF VITAMIN PP COMPOUNDS KLINGE PHARMA GMBH (DE) 1999-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12357547-B2 Compositions containing microcapsules COPE, SAAL1, AUP1 KDM4C 4468/4885KDM6B 4480/4885GABRP 2038/4885
US-12324452-B2 Delivery systems and methods of preparing the same MAL2, TAS2R42, TAS2R31 KDM4C 631/4885KDM6B 2316/4885GABRP 2680/4885
US-12419815-B2 Microcapsule compositions stabilized with viscosity control agents ACR, ALG1, MLEC KDM4C 4508/4885KDM6B 4611/4885GABRP 3444/4885
US-20260041109-A1 ROBUST FLAVOR EMULSIONS ACACA, FABP4, CUTA KDM4C 4017/4885KDM6B 4525/4885GABRP 3442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.